Subtopic Deep Dive
Non-Homologous End Joining
Research Guide
What is Non-Homologous End Joining?
Non-Homologous End Joining (NHEJ) is the primary pathway for repairing DNA double-strand breaks in mammalian cells by directly ligating broken ends without requiring homologous template sequences.
NHEJ involves the Ku70/Ku80 heterodimer, DNA-PKcs, XRCC4, and Ligase IV to process and join DSB ends. This error-prone mechanism dominates in G1 phase and supports V(D)J recombination for immunity (Chang et al., 2017, 1656 citations). Alternative NHEJ pathways emerge when classical NHEJ fails (Scully et al., 2019, 1439 citations).
Why It Matters
NHEJ defects cause genomic instability, contributing to cancer via chromosomal rearrangements, as seen in PARP inhibitor sensitivity in BRCA-mutant tumors where synthetic lethality exploits HR deficiency and elevates NHEJ reliance (Fong et al., 2009, 3582 citations). NHEJ enables adaptive immunity through V(D)J recombination but errors drive leukemogenesis. Radiation therapy targets DSBs, where NHEJ efficiency modulates tumor cell survival (Rogakou et al., 1999, 2399 citations). Therapeutic PARP inhibitors like olaparib succeed clinically against NHEJ-overburdened cells.
Key Research Challenges
Error-prone joining mechanisms
NHEJ often introduces insertions or deletions at junctions, complicating precise repair modeling. Microhomology-mediated alt-NHEJ competes with classical NHEJ, blurring pathway distinctions (Chang et al., 2017). Quantifying error rates in vivo remains difficult.
Pathway choice regulation
Cells select NHEJ over HR based on cell cycle and DSB context, influenced by 53BP1 and ATM signaling. Dysregulation favors alt-NHEJ in HR-deficient cancers (Scully et al., 2019). Chromatin structure modulates accessibility (Rogakou et al., 1999).
Therapeutic targeting precision
Inhibiting DNA-PK or Ligase IV sensitizes tumors to radiation but risks normal tissue toxicity. PARP-NHEJ interplay enables synthetic lethality, yet resistance emerges via pathway shifts (Fong et al., 2009). Clinical translation lags due to off-target effects.
Essential Papers
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers
Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · 2009 · New England Journal of Medicine · 3.6K citations
Olaparib has few of the adverse effects of conventional chemotherapy, inhibits PARP, and has antitumor activity in cancer associated with the BRCA1 or BRCA2 mutation. (ClinicalTrials.gov number, NC...
Shelterin: the protein complex that shapes and safeguards human telomeres
Titia de Lange · 2005 · Genes & Development · 3.0K citations
Added by telomerase, arrays of TTAGGG repeats specify the ends of human chromosomes. A complex formed by six telomere-specific proteins associates with this sequence and protects chromosome ends. B...
Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Emmy P. Rogakou, Chye Boon, Christophe E. Redon et al. · 1999 · The Journal of Cell Biology · 2.4K citations
The loss of chromosomal integrity from DNA double-strand breaks introduced into mammalian cells by ionizing radiation results in the specific phosphorylation of histone H2AX on serine residue 139, ...
The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms
Matt Kaeberlein, Mitch McVey, Leonard Guarente · 1999 · Genes & Development · 2.2K citations
The SIR genes are determinants of life span in yeast mother cells. Here we show that life span regulation by the Sir proteins is independent of their role in nonhomologous end joining. The short li...
Cell cycle checkpoint signaling through the ATM and ATR kinases
Robert T. Abraham · 2001 · Genes & Development · 2.0K citations
The genomes of eukaryotic cells are under continuous assault by environmental agents (e.g., UV light and reactive chemicals) as well as the byproducts of normal intracellular metabolism (e.g., reac...
Cytokinesis-block micronucleus cytome assay
Michael Fenech · 2007 · Nature Protocols · 1.9K citations
Non-homologous DNA end joining and alternative pathways to double-strand break repair
Howard H. Chang, Nicholas R. Pannunzio, Noritaka Adachi et al. · 2017 · Nature Reviews Molecular Cell Biology · 1.7K citations
Reading Guide
Foundational Papers
Start with Chang et al. (2017) for NHEJ mechanisms overview (1656 citations), Rogakou et al. (1999) for DSB detection via γ-H2AX (2399 citations), and Fong et al. (2009) for therapeutic context (3582 citations).
Recent Advances
Scully et al. (2019, 1439 citations) details pathway choice; complements Chang et al. (2017) on alt-NHEJ.
Core Methods
Ku heterodimer binding, DNA-PKcs activation, end-processing by PNKP/Polμ, Ligase IV sealing (Chang et al., 2017); γ-H2AX foci quantification (Rogakou et al., 1999).
How PapersFlow Helps You Research Non-Homologous End Joining
Discover & Search
Research Agent uses searchPapers and citationGraph to map NHEJ core papers from Ku-DNA-PKcs-LigIV, revealing Chang et al. (2017) as a central node with 1656 citations linking to Fong et al. (2009) PARP applications; exaSearch uncovers obscure alt-NHEJ studies, while findSimilarPapers expands from Scully et al. (2019) pathway choice review.
Analyze & Verify
Analysis Agent applies readPaperContent to extract Ku-binding kinetics from Chang et al. (2017), verifies NHEJ efficiency claims via verifyResponse (CoVe) against Rogakou et al. (1999) γ-H2AX data, and runs PythonAnalysis for statistical modeling of junction microhomologies using pandas on extracted sequences; GRADE grading scores evidence strength for V(D)J claims.
Synthesize & Write
Synthesis Agent detects gaps in alt-NHEJ quantification across papers, flags contradictions between classical vs. alt-NHEJ dominance; Writing Agent uses latexEditText for pathway diagrams, latexSyncCitations to integrate 10+ NHEJ papers, and latexCompile for camera-ready reviews with exportMermaid for DSB repair flowcharts.
Use Cases
"Model NHEJ junction deletion frequencies from published sequences"
Research Agent → searchPapers('NHEJ junction sequences') → Analysis Agent → readPaperContent → runPythonAnalysis (pandas length distribution, matplotlib histograms) → researcher gets CSV of indel stats and plots.
"Write LaTeX review on NHEJ in BRCA tumors"
Synthesis Agent → gap detection → Writing Agent → latexEditText (draft sections) → latexSyncCitations (Fong 2009 et al.) → latexCompile → researcher gets PDF with synced bibliography and figures.
"Find code for simulating NHEJ repair outcomes"
Research Agent → paperExtractUrls → Code Discovery → paperFindGithubRepo → githubRepoInspect → researcher gets verified Python repos modeling end-processing enzymes.
Automated Workflows
Deep Research workflow conducts systematic NHEJ review: searchPapers(50+ hits) → citationGraph → DeepScan (7-step verifyResponse/CoVe on pathway claims) → structured report with GRADE scores. Theorizer generates hypotheses on DNA-PKcs inhibition from Chang et al. (2017) + Fong et al. (2009) synthetic lethality. DeepScan analyzes γ-H2AX focus kinetics (Rogakou et al., 1999) with runPythonAnalysis checkpoints.
Frequently Asked Questions
What defines Non-Homologous End Joining?
NHEJ ligates DSB ends via Ku-DNA-PKcs-XRCC4-Ligase IV without homology, operating mainly in G1 (Chang et al., 2017).
What are key NHEJ methods studied?
Classical NHEJ uses synapsis and ligation; alt-NHEJ relies on microhomologies; both compete with HR (Scully et al., 2019).
What are seminal NHEJ papers?
Chang et al. (2017, 1656 citations) reviews mechanisms; Fong et al. (2009, 3582 citations) shows PARP-NHEJ therapy; Rogakou et al. (1999, 2399 citations) links to γ-H2AX.
What open problems exist in NHEJ?
Regulating pathway choice in cancer; predicting junction errors quantitatively; overcoming resistance to DNA-PK/PARP inhibitors.
Research DNA Repair Mechanisms with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching Non-Homologous End Joining with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the DNA Repair Mechanisms Research Guide